儿童ARDS中隐匿性与显性急性肾损伤具有相似的生物标志物特征
该观察性研究纳入四级PICU中333例儿童ARDS患者,比较隐匿性AKI(液体过负荷校正肌酐诊断)、KDIGO定义AKI与无AKI三组的生物标志物及临床结局。结果显示隐匿性AKI与KDIGO AKI的血管生成素-2、III型前胶原N端肽、热休克蛋白70、肿瘤坏死因子受体1和白细胞介素-8均显著高于无AKI组,且隐匿性AKI死亡率更高、住院时间更长,与KDIGO AKI相似。提示隐匿性AKI代表真实肾损伤,临床应关注液体过负荷对肌酐判读的影响。
要点
- 儿童ARDS患者中,使用液体过负荷校正肌酐可诊断出传统KDIGO标准漏诊的隐匿性AKI。
- 隐匿性AKI患者死亡率更高、住院时间更长,与KDIGO AKI患者相似,均差于无AKI患者。
- 隐匿性AKI与KDIGO AKI的血管生成素-2、III型前胶原N端肽、热休克蛋白70、肿瘤坏死因子受体1和白细胞介素-8均显著高于无AKI组。
- 儿童ARDS患者评估肾功能时,应考虑液体过负荷对血清肌酐的干扰,避免漏诊隐匿性AKI。
适用人群与场景
- 四级PICU中333例儿童ARDS患者,观察性研究人群。
诊断标准与关键阈值
- 隐匿性AKI:采用液体过负荷校正肌酐诊断的AKI,即传统KDIGO定义会漏诊的AKI。
- KDIGO AKI:传统KDIGO定义诊断的AKI。
- 无AKI:不符合上述AKI诊断者。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 观察性研究,单中心四级PICU,纳入333例儿童ARDS患者。
- 隐匿性AKI与KDIGO AKI患者死亡率均高于无AKI患者,住院时间均长于无AKI患者,隐匿性AKI与KDIGO AKI之间相似。
- 第1、3、7天生物标志物:血管生成素-2、III型前胶原N端肽、热休克蛋白70、肿瘤坏死因子受体1和白细胞介素-8在隐匿性AKI和KDIGO AKI组均显著高于无AKI组。
- 隐匿性AKI与KDIGO AKI的生物标志物谱相似,而与无AKI患者不同。
证据类型、等级与局限
- 观察性研究,单中心,样本量333例,原文未提及证据等级或推荐强度。
- 局限:单中心、观察性设计,原文未提及盲法或前瞻性验证。
对床旁实践的改变
- 儿童ARDS患者评估AKI时,应警惕液体过负荷导致的肌酐稀释,考虑使用液体过负荷校正肌酐以识别隐匿性AKI。
- 隐匿性AKI并非良性,其生物标志物谱与KDIGO AKI相似且预后更差,不应因传统KDIGO标准未达标而忽视。
- 原文未提及具体干预措施,不能由本研究推断治疗改变。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Patients with acute respiratory distress syndrome (ARDS) are at risk for higher morbidity and mortality with concurrent acute kidney injury (AKI). AKI diagnosis relies on serum creatinine, which is confounded by fluid overload. Use of fluid overload-adjusted creatinine can diagnose AKI (termed Cryptic AKI) that would otherwise be missed by the traditional Kidney Disease Improving Global Outcomes (KDIGO) definition. It is unknown whether Cryptic AKI is biochemically distinct from patients without AKI.
OBJECTIVES: Determine whether pediatric ARDS patients with Cryptic AKI have a biochemical profile that is similar or distinct from patients with KDIGO-defined AKI or no AKI.
DESIGN SETTING AND PARTICIPANTS: Observational study of 333 pediatric ARDS patients in a quaternary PICU.
MAIN OUTCOMES AND MEASURES: Mortality, length of stay, and ventilator-free days were measured for all patients. Biomarkers indicative of tissue damage and inflammation were measured on days 1, 3, and 7 of ARDS.
RESULTS: Cryptic AKI was associated with higher mortality and longer length of stay than no AKI, similar to KDIGO AKI. Biomarkers angiopoietin-2, pro-collagen III N-terminal peptide, heat shock protein 70, tumor necrosis factor receptor 1, and interleukin-8 were significantly higher in Cryptic and KDIGO AKI than in no AKI.
CONCLUSIONS AND RELEVANCE: Cryptic AKI is clinically significant and represents true kidney injury, with a biomarker profile similar to KDIGO AKI and distinct from patients without AKI.
参考来源
- Dixon CG, Lee AM, Fitzgerald JC, et al. Cryptic and Overt Acute Kidney Injury Share Biomarker Characteristics in Pediatric Acute Respiratory Distress Syndrome. Crit Care Explor. 2026. PMID: 42708120. doi:10.1097/CCE.0000000000001482
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。